Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online

    Output of New Molecular Entities Drops to Historic Low as Pharma Companies
    Face Increasing Competition from Generics Companies

    LONDON, July 24 /CNW/ -- The Scientific business of Thomson Reuters today
announced the availability of the newly published CMR International 2008
Pharmaceutical R&D Factbook, an indispensable reference and business planning
tool for decision makers in pharmaceutical R&D, corporate finance, business
strategy, marketing planning and corporate communications.  This year's
Factbook offers a comprehensive and up-to-date overview of emerging trends in
worldwide pharmaceutical R&D and has been considerably enhanced with data
sourced from other Thomson Reuters businesses providing insight into areas
such as generic drugs and patents.
    CMR International's research shows that the output of new molecular
entities (NMEs) fell to a new 20 year low despite continued year-on-year
increases in R&D expenditure.  The proportion of sales derived from products
first launched within the last five years dropped to below 10%, leaving
pharmaceutical companies open to the threat of patent expiry.  As R&D
companies are attempting to reverse the decline in the Pharma Industry's
productivity, it is clear that competition from the generics sector is rapidly
increasing.  In particular, generics manufacturers in India are having an
increased impact.
    "The R&D Factbook has highlighted the challenges faced by the
pharmaceutical industry, with a decrease in new drugs reaching the marketplace
in 2007 and an increasing number of generics manufacturers expanding their
capabilities to exploit expiring patents," said Alexander Karle, Vice
President and General Manager of CMR International.  "Our research shows that
those companies best able to manage portfolio risk, drive efficiency through
effective development and maximize the return from alliances and
collaborations will be best placed to succeed in the coming years."
    The information found in the Factbook is based on primary sources
covering major pharmaceutical companies that account for approximately 80% of
the industry's global R&D expenditure.  The CMR International 2008
Pharmaceutical R&D Factbook is available as a hard copy report, or in
single-user or enterprise-wide electronic format supplied on CD-ROM.
    For further information and an opportunity to purchase the Factbook,
please go to:
    About Thomson Reuters
    Thomson Reuters is the world's leading source of intelligent information
for businesses and professionals.  We combine industry expertise with
innovative technology to deliver critical information to leading decision
makers in the financial, legal, tax and accounting, scientific, healthcare and
media markets, powered by the world's most trusted news organization. With
headquarters in New York and major operations in London and Eagan, Minnesota,
Thomson Reuters employs more than 50,000 people in 93 countries. For more
information, go to

For further information:

For further information: Eoin Bedford, PR Manager of Scientific,
+44(0)2074334691,, for Thomson Reuters Web

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890